Big Move For Sophiris Bio, Inc.

Mon 27 Jan 20 at 05:30 PM
Big Move For Sophiris Bio, Inc.

Sophiris Bio, Inc. (SPHS:NASDAQ) rocketted at $0.86, representing a gain of 27.2%. From Fri 03 Jan 20, the stock recorded 35.71% Up Days and 46.67% Green Days

About Sophiris Bio, Inc. (SPHS:NASDAQ)

Sophiris Bio Inc is a clinical-stage biopharmaceutical company. The Company is engaged in research and development of products for the treatment of urological diseases. It is currently developing PRX302 for treatment of benign prostatic hyperplasia.